With an objective to attain self-reliance and reduce import dependence in India’s pharmaceutical sector, the government has cleared 19 applications with a committed investment of Rs 4,623.01 crore under its ambitious production linked incentive (PLI) scheme for the promotion of domestic manufacturing of critical key drug intermediates and active pharmaceutical ingredients (APIs)
